ONL THERAPEUTICS, INC.

Profile

Company Names

ONL THERAPEUTICS, INC.

Addresses

524 S. MAIN ST, SUITE 110, ANN ARBOR, MI 48104

524 S. MAIN STREET, SUITE 110, ANN ARBOR, MI 48104

1600 HURON PARKWAY, BUILDING 520, SECOND FLOOR, ANN ARBOR, MI 48109

1600 HURON PARKWAY, SECOND FLOOR, ANN ARBOR, MI 48109

Phone Numbers

(734) 412-8787
734-412-8787
734-926-5530

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2011

State Incorporated:

DELAWARE

Total Amount Raised:

$111,494,562.00

Number of Funding Rounds:

10
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
10
2024-09-12 
$59,999,998.00 
$65,000,002.00 
$5,000,004.00 
Equity 
9
2024-02-29 
$9,999,948.00 
$10,000,000.00 
$52.00 
Equity 
8
2023-03-07 
$4,999,956.00 
$15,000,000.00 
$10,000,044.00 
Equity 
7
2020-12-18 
$26,802,122.00 
$47,359,054.00 
$20,556,932.00 
Equity 
6
2020-10-19 
$2,000,000.00 
$2,000,000.00 
$0.00 
 
5
2019-08-15 
$3,000,000.00 
$3,000,000.00 
$0.00 
Debt 
4
2018-09-07 
$639,000.00 
$1,000,000.00 
$361,000.00 
Debt 
3
2017-05-12 
$2,635,567.00 
$4,338,067.00 
$1,702,500.00 
Equity 
2
2016-08-01 
$916,161.00 
$1,200,000.00 
$283,839.00 
Debt 
1
2014-06-17 
$501,810.00 
$1,000,000.00 
$498,190.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
WILLIAM 
 
BRINKERHOFF 
DIRECTOR
BILL 
 
BURNS 
DIRECTOR
RAFAEL 
 
CASTILLA 
DIRECTOR
CONSTANCE 
 
CHANG 
EXECUTIVE OFFICER
LOIC 
 
COURAUD 
DIRECTOR
FELICIA 
 
DAVID-VISSER 
DIRECTOR
DAVID 
 
ESPOSITO 
EXECUTIVE OFFICER, DIRECTOR
JOHN 
 
FRESHLEY 
EXECUTIVE OFFICER, DIRECTOR
JOHN 
FRESHLEY 
EXECUTIVE OFFICER, DIRECTOR
CHRISTINE 
 
GIBBONS 
DIRECTOR
MARK 
 
HOOPER 
DIRECTOR
JEFFREY 
JAMISON 
EXECUTIVE OFFICER
STELLA 
 
ROBERTSON 
DIRECTOR
DAVID 
 
ZACKS 
EXECUTIVE OFFICER, DIRECTOR
DAVID 
ZACKS 
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-09-12 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-02-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-03-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-18 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2020-10-19 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-08-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-09-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-05-12 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-08-01 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-06-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#